GlassScriptPhysician profile
Audrey N Green
NPI 1962834259
$2,239.57
in general payments reported to CMS, 2019-2025
21 companies · $94.12 in 2025
The $94.12 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $655 · 2020: $134 · 2021: $274 · 2022: $838 · 2023: $93.33 · 2024: $152 · 2025: $94.12.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $339.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $339.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $459.66 | 2019-2024 | |
| Pfizer INC. | $260.25 | 2019-2025 | |
| Genzyme Corporation | $196.18 | 2021-2023 | |
| Amgen INC. | $176.14 | 2020-2025 | Otezla, Otezla |
| Galderma Laboratories, L.P. | $165.47 | 2019-2022 | |
| Incyte Corporation | $162.44 | 2021-2024 | Opzelura |
| Allergan, INC. | $146.57 | 2019-2022 | |
| Ucb, INC. | $124.35 | 2019-2024 | Bimzelx |
| Sun Pharmaceutical Industries INC. | $110.65 | 2021-2024 | Ilumya |
| Regeneron Healthcare Solutions, INC. | $83.50 | 2019-2020 | |
| Genentech USA, INC. | $51.02 | 2019 | |
| Mayne Pharma Commercial LLC | $49.59 | 2019 | |
| Leo Pharma INC. | $47.37 | 2022 | |
| Aclaris Therapeutics, INC. | $46.31 | 2019 | |
| Celgene Corporation | $37.73 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $30.36 | 2022 | |
| Mimedx Group, INC. | $25.50 | 2025 | |
| Organogenesis INC. | $21.00 | 2023 | Puraply |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $15.62 | 2022 | |
| Hologic Sales and Service, LLC | $15.38 | 2021 | |
| Helsinn Therapeutics (U.S.), INC. | $14.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Audrey Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.